MétaCan
Menu
Back to cohort
Record W3197649229 · doi:10.1002/ehf2.13517

The Genomics of Heart Failure: Design and Rationale of the HERMES Consortium

2021· article· en· W3197649229 on OpenAlexafffund
R Thomas Lumbers, Sonia Shah, Honghuang Lin, Tomasz Czuba, Albert Henry, Daniel I. Swerdlow, Anders Mälarstig, Charlotte Andersson, Niek Verweij, Michael V. Holmes, Johan Ärnlöv, Per Svensson, Harry Hemingway, Neneh Sallah, Peter Almgren, Krishna G. Aragam, Géraldine Asselin, Joshua Backman, Mary L. Biggs, Heather L. Bloom, Eric Boersma, Jeffrey Brandimarto, Michael R. Brown, Hans‐Peter Brunner‐La Rocca, David J. Carey, Mark Chaffin, Daniel I. Chasman, Olympe Chazara, Xing Chen, Xu Chen, Jonathan H. Chung, William A. Chutkow, John G.F. Cleland, James P. Cook, Simon de Denus, Abbas Dehghan, Graciela E. Delgado, Spiros Denaxas, Alex S. F. Doney, Marcus Dörr, Samuel C. Dudley, Gunnar Engström, Tõnu Esko, Ghazaleh Fatemifar, Stephan B. Felix, Chris Finan, Ian Ford, Françoise Fougerousse, René Fouodjio, Mohsen Ghanbari, Sahar Ghasemi, Vilmantas Giedraitis, Franco Giulianini, John S. Gottdiener, Stefan Groß, Daníel F. Guðbjartsson, Hongsheng Gui, Rebecca Gutmann, Christopher M. Haggerty, Pim van der Harst, Åsa K. Hedman, Anna Helgadóttir, Hans L. Hillege, Craig Hyde, Jaison Jacob, J. Wouter Jukema, Frederick Kamanu, Isabella Kardys, Maryam Kavousi, Kay‐Tee Khaw, Marcus E. Kleber, Lars Køber, Andrea Koekemoer, Bill Kraus, Karoline Kuchenbaecker, Claudia Langenberg, Lars Lind, Cecilia M. Lindgren, Barry London, Luca A. Lotta, Ruth C. Lovering, Jian’an Luan, Patrik K. E. Magnusson, Anubha Mahajan, Douglas L. Mann, Kenneth B. Margulies, Nicholas Marston, Winfried März, John J.V. McMurray, Olle Melander, Giorgio Melloni, Ify Mordi, Michael P. Morley, Andrew D. Morris, Andrew P. Morris, Alanna C. Morrison, Michael W. Nagle, Christopher P. Nelson, Christopher Newton‐Cheh, Alexander Niessner, Teemu Niiranen, Christoph Nowak, Michelle L. O’Donoghue, Anjali Owens, Guillaume Paré, Markus Perola, Louis‐Philippe Lemieux Perreault, Eliana Portilla-Fernández, Bruce M. Psaty, Kenneth Rice, Paul M. Ridker, Simon P.R. Romaine, Carolina Roselli, Jerome I. Rotter, Christian T. Ruff, Marc S. Sabatine, Perttu Salo, Veikko Salomaa, Jessica van Setten, Alaa Shalaby, Diane T. Smelser, Nicholas L. Smith, Steen Stender, David J. Stott, Garðar Sveinbjörnsson, Mari‐Liis Tammesoo, Jean‐Claude Tardif, Kent D. Taylor, Maris Teder‐Laving, Alexander Teumer, Guðmundur Þorgeirsson, Unnur Þorsteinsdóttir, Christian Torp‐Pedersen, Stella Trompet, Danny Tuckwell, Benoît Tyl, André G. Uitterlinden, Felix Vaura, Abirami Veluchamy, Peter M. Visscher, Uwe Völker, Adriaan A. Voors, Xiaosong Wang, Nicholas J. Wareham, Peter Weeke, Raul Weiss, Harvey D. White, Kerri L. Wiggins, Heming Xing, Jian Yang, Yifan Yang, Laura M. Yerges‐Armstrong, Bing Yu, Faı̈ez Zannad, Faye Zhao, Jemma B. Wilk, Hilma Hólm, Naveed Sattar, Steven A. Lubitz, David E. Lanfear, Svati H. Shah, Michael E. Dunn, Quinn S. Wells, Folkert W. Asselbergs, Aroon D. Hingorani, Marie‐Pierre Dubé, Nilesh J. Samani, Chim C. Lang, Thomas P. Cappola, Patrick T. Ellinor, Ramachandran S. Vasan, J. G. Smith

Bibliographic record

VenueESC Heart Failure · 2021
Typearticle
Languageen
FieldMedicine
TopicCardiovascular Function and Risk Factors
Canadian institutionsMcMaster UniversityAmgen (Canada)Université de MontréalMontreal Heart Institute
FundersNational Heart, Lung, and Blood InstituteUCLH Biomedical Research CentreAmerican RegentNational Institutes of HealthRoy J. and Lucille A. Carver College of Medicine, University of IowaEsperion TherapeuticsEuropean Research CouncilTerveyden ja hyvinvoinnin laitosKarl-Franzens-Universität GrazUniversity College London Hospitals NHS Foundation TrustMedical Research CouncilServierUppsala UniversitetAalborg UniversitetshospitalMedizinische Universität WienMedical Center, University of PittsburghTurun YliopistoSkånes universitetssjukhusRigshospitaletNetherlands Heart InstituteUniversitair Medisch Centrum GroningenLeids Universitair Medisch CentrumVetenskapsrådetEisaiLunds UniversitetCrafoordska StiftelsenRegeneron PharmaceuticalsUniversität WienUniversity of GlasgowUniversiteit LeidenStiftelsen för Strategisk ForskningMcMaster UniversityUniversity of OxfordHjärt-LungfondenFramingham Heart StudyAmerican Heart AssociationEvans Medical FoundationHealth Data Research UKBrigham and Women's HospitalEuropean Federation of Pharmaceutical Industries and AssociationsDepartment of Orthopaedic Surgery, Boston University School of MedicineAmgenUniversité de MontréalOhio State UniversityHáskóli ÍslandsBritish Heart FoundationStiftelsen för Strategisk ForskningUniversity of PittsburghNIHR Leicester Biomedical Research CentreMedizinische Universität GrazU.S. Department of Veterans AffairsYale UniversityOffice of Research and DevelopmentUK Research and InnovationMassachusetts General HospitalAalborg UniversitetEli Lilly and CompanyNational Center for Advancing Translational SciencesKaiser PermanenteGlaxoSmithKlineNational Institute of Diabetes and Digestive and Kidney DiseasesTurun Yliopistollinen KeskussairaalaKnut och Alice Wallenbergs StiftelseBayerGentofte HospitalNational Institute for Health and Care ResearchCSL BehringRijksuniversiteit GroningenUniversity of LeicesterBristol-Myers SquibbAmarin CorporationErasmus Universitair Medisch Centrum RotterdamGenentechAstraZenecaUniversity of WashingtonPfizerSanofiBroad InstituteSchool of Medicine, Boston University
KeywordsHeart failureMedicineGenomicsInternal medicineIntensive care medicineGeneticsBiologyGenome

Abstract

fetched live from OpenAlex

Abstract Aims The HERMES (HEart failure Molecular Epidemiology for Therapeutic targetS) consortium aims to identify the genomic and molecular basis of heart failure. Methods and results The consortium currently includes 51 studies from 11 countries, including 68 157 heart failure cases and 949 888 controls, with data on heart failure events and prognosis. All studies collected biological samples and performed genome-wide genotyping of common genetic variants. The enrolment of subjects into participating studies ranged from 1948 to the present day, and the median follow-up following heart failure diagnosis ranged from 2 to 116 months. Forty-nine of 51 individual studies enrolled participants of both sexes; in these studies, participants with heart failure were predominantly male (34–90%). The mean age at diagnosis or ascertainment across all studies ranged from 54 to 84 years. Based on the aggregate sample, we estimated 80% power to genetic variant associations with risk of heart failure with an odds ratio of ≥1.10 for common variants (allele frequency ≥ 0.05) and ≥1.20 for low-frequency variants (allele frequency 0.01–0.05) at P < 5 × 10−8 under an additive genetic model. Conclusions HERMES is a global collaboration aiming to (i) identify the genetic determinants of heart failure; (ii) generate insights into the causal pathways leading to heart failure and enable genetic approaches to target prioritization; and (iii) develop genomic tools for disease stratification and risk prediction.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.176
metaresearch head score (Gemma)0.073
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.176
Threshold uncertainty score0.928

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1760.073
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0030.003
Science and technology studies0.0040.005
Scholarly communication0.0040.002
Open science0.0040.012
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0110.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.228
Teacher spread0.215 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations22
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueESC Heart FailureSame topicCardiovascular Function and Risk FactorsFrench-language works237,207